Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

NVCR holding history

NovoCure Ltd in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVCR overviewAll 13F holders of NVCRFull Q2 2026 holdings

Shares (Q2 2026)
1,022,480
Value
$15.5M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of NVCR by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,022,480$15.5M<0.1%+375,418+58.0%AddedHolders
Q1 2026647,062$7.05M<0.1%−175,323−21.3%ReducedHolders
Q4 2025822,385$10.6M<0.1%+335,906+69.0%AddedHolders
Q3 2025486,479$6.29M<0.1%+465,923+2,266.6%AddedHolders
Q2 202520,556$365.9K<0.1%+20,556NewHolders
Q1 20250$00.0%−185,303−100.0%Sold outHolders
Q4 2024185,303$5.52M<0.1%−465,011−71.5%ReducedHolders
Q3 2024650,314$10.2M<0.1%−48,980−7.0%ReducedHolders
Q2 2024699,294$12.0M<0.1%−254,618−26.7%ReducedHolders
Q1 2024953,912$14.9M<0.1%−411,405−30.1%ReducedHolders
Q4 20231,365,317$20.4M<0.1%+1,013,867+288.5%AddedHolders
Q3 2023351,450$5.68M<0.1%+295,866+532.3%AddedHolders
Q2 202355,584$2.31M<0.1%+22,567+68.3%AddedHolders
Q1 202333,017$1.99M<0.1%+15,017+83.4%AddedHolders
Q4 202218,000$1.32M<0.1%+6,697+59.2%AddedHolders
Q3 202211,303$859.0K<0.1%+4,689+70.9%AddedHolders
Q2 20226,614$460.0K<0.1%+6,614NewHolders
Q4 20210$00.0%−85,016−100.0%Sold outHolders
Q3 202185,016$9.88M<0.1%−65,085−43.4%ReducedHolders
Q2 2021150,101$33.3M<0.1%+15,185+11.3%AddedHolders
Q1 2021134,916$17.8M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.